Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
Search result
<
Price history for Gemcitabin Sandoz 200 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Gemcitabin Sandoz 200 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung - Flasche(n) - 61449 001 -
Art. 24 ATSG
Datum
Exfactory price
Public price
Price origin
Data sources
Mutation codes
01.07.2024
37.60
(-3.22 %)
LS
http://www.xn--spezialittenliste-yqb.ch/File.axd?file=XMLPublications.zip
(01.07.2024)
PREISMUTATION EINHEITLICHER VA
01.01.2024
38.85
(+0.13 %)
LS
http://www.xn--spezialittenliste-yqb.ch/File.axd?file=XMLPublications.zip
(01.01.2024)
MWSTAENDERUNG
01.12.2021
19.52
(-0.36 %)
38.80
(-0.26 %)
LS
http://www.xn--spezialittenliste-yqb.ch/File.axd?file=XMLPublications.zip
(01.12.2021)
Voluntary price reduction
01.12.2020
19.59
(-0.56 %)
38.90
(-0.26 %)
LS
http://www.xn--spezialittenliste-yqb.ch/File.axd?file=XMLPublications.zip
(01.12.2020)
Voluntary price reduction
01.12.2019
19.70
(-1.10 %)
39.00
(-0.64 %)
LS
http://bag.e-mediat.net/SL2007.Web.External/File.axd?file=XMLPublications.zip
(01.12.2019)
Voluntary price reduction
01.12.2018
19.92
(-1.87 %)
39.25
(-1.13 %)
LS
http://bag.e-mediat.net/SL2007.Web.External/File.axd?file=XMLPublications.zip
(01.12.2018)
Voluntary price reduction
01.02.2018
20.30
(-18.80 %)
39.70
(-11.97 %)
LS
http://bag.e-mediat.net/SL2007.Web.External/File.axd?file=XMLPublications.zip
(01.02.2018)
Voluntary price reduction
01.01.2016
25.00
(-3.85 %)
45.10
(-2.49 %)
LS
http://bag.e-mediat.net/SL2007.Web.External/File.axd?file=XMLPublications.zip
(24.12.2015)
Voluntary price reduction
01.05.2011
26.00
46.25
LS
http://bag.e-mediat.net/SL2007.Web.External/File.axd?file=XMLPublications.zip
(02.05.2011)
Initial registration in SL
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home